Overall, these data suggested the capacity of Nano-reshaper to inhibit GBM growth and CD8+ T cells were the key immune cell subpopulation that primarily drove the antitumor activity, and peripheral T-cell infiltration was essential for this therapeutic strategy to maintain the tumor control. Here, CD8A is linked to glioblastoma.